Welldoc, Inc

Description

• WellDoc®, maker of the first FDA cleared Mobile Prescription Therapy, develops mobile health products that engage patients and enhance health outcomes. As a digital technology company, WellDoc focus's on simplifying the way chronic diseases are managed through a collaborative, life-changing approach that breaks down the barriers of engagement and care plan adherence. WellDocs flagship product, BlueStar, is the first and only Mobile Prescription Therapy. This FDA cleared, patient-centered product is recognized by the American Diabetes Association (ADA) as a first-in-class treatment for the 24 million adults living with type 2 diabetes. BlueStar, requires a prescription (RxOnly) from a licensed healthcare provider and can be dispensed and reimbursed through a pharmacy. This therapy is powered by WellDocs proprietary platform, an Automated Expert Analytics System, and it enables patients to self-manage their diabetes through real-time motivational, behavioral and educational coaching. BlueStar also coordinates care by helping patients adhere to their treatment plan while providing clinical decision support to the patients healthcare provider to optimize treatment decisions. Forbes selected WellDoc as one of America's Most Promising Companies based on its potential for future growth, and in January 2014, WellDoc closed a $20 million Series A led by the Merck Global Health Innovation Fund. Visit us at: www.welldoc.com or www.bluestardiabetes.com
• 

  Headquarters:10221 Wincopin Circle Suite 150, Columbia, Maryland, United States

  More
• 

  Phone Number: +1 443-692-3100

• 

  Website: https://www.welldoc.com

• 

  Employees:105

• 

  Revenue:$10 - 50M

• 

  Legal Name:Welldoc, Inc

• Welldoc, Inc's Social Media

  
• Is this data correct?

• |  NAICS Code: 524114  |

  Show More